Search results
Results from the WOW.Com Content Network
Azilsartan, sold under the brand name Edarbi among others, is used for the treatment of hypertension. [2] [3] [4] It is used as the prodrug azilsartan medoxomil, is an angiotensin II receptor antagonist, [5] and was developed by Takeda. The most common adverse reaction in adults is diarrhea. [2] It is available as a generic medication. [6]
Pregnancy occurs in about 0.3% of women with perfect use and 9% of women with typical use. [5] Common side effects include irregular vaginal bleeding, nausea, sore breasts, vaginitis, mood changes, and headache. [6] Rare but serious side effects may include blood clots, toxic shock syndrome, anaphylaxis, gallstones, and liver problems. [6]
The FDA approval was conditioned on Mitsubishi Tanabe completing several additional studies to clarify the risks of cancer and liver disease, among other effects of the medication. [ 14 ] [ 15 ] A formulation of edaravone by mouth, which is a mixture of edaravone and SBE-HP-βCD, [ 16 ] has been under development by Ferrer (called FAB122) and ...
They come with a risk of side effects like nausea and diarrhea, ... Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50. Show comments. Advertisement. Advertisement. In ...
Side effects include irregular heartbeat, fatigue, high blood pressure, dry mouth, and eyes that are itchy, red, and/or swollen. Carbonic anhydrase inhibitors (Trusopt, Azopt): This is another ...
A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's what a doctor wants you to know.
The general side effects of EE include breast tenderness and enlargement, headache, fluid retention, and nausea among others. [7] In men, EE can additionally cause breast development, feminization in general, hypogonadism, and sexual dysfunction. Rare but serious side effects include blood clots, liver damage, and cancer of the uterus. [7]
GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. (Reminder that there are many of these meds now. GLP-1s ...